Newer Treatment Approaches for Type 2 Diabetes Mellitus

Folyóirat címe
Folyóirat ISSN
Kötet címe (évfolyam száma)

Type 2 diabetes mellitus is a chronic metabolic disorder that results from defects in both insulin secretion and insulin action. Type 2 diabetes can initially be treated with oral agent monotherapy, but due to the progressive nature of this disorder, patients eventually require the addition of other oral agents, often as a prelude to insulin therapy. Several new approaches are developed to improve glycemic control with minimum side effects.

diabetes mellitus type 2, anti-diabetic drugs, sulfonylureas, rapid-acting insulin secretagogues, metformin, thiazolidinediones, α-glucosidase inhibitors, incretin analogue based therapies 19 glucagon-like-peptide-1 receptor agonist, dipeptidyl peptidase-4 inhibitors, sodium-glucose co-transporter type 2 inhibitors, pramlintide